Clinical Outcomes and Donor-specific Antibody Rebound 5 y After Kidney Transplant Enabled by Imlifidase Desensitization.

Background: Imlifidase is an IgG-cleaving endopeptidase conditionally approved in Europe for desensitization of highly sensitized patients before kidney transplantation. We present 5-y outcomes and donor-specific antibody (DSA) levels for clinical trial participants from a single site who received imlifidase for desensitization before incompatible transplantation (NCT02790437).

Methods: Imlifidase was administered up to 24 h before living or deceased donor kidney transplantation.

HLA EPLET Frequencies Are Similar in Six Population Groups and Are Expressed by the Most Common HLA Alleles.

The degree of immunological compatibility between donors and recipients greatly impacts allograft survival. In the United States kidney allocation system, HLA antigen-level matching has been shown to cause ethnic disparities and thus, has been de-emphasised. However, priority points are still awarded for antigen-level zero-ABDR matching, zero-DR matching and one-DR matching.

: An R Package to Calculate ActiGraph Activity Counts From Portable Accelerometers.

Portable accelerometers are used to capture physical activity in free-living individuals with the ActiGraph being one of the most widely used device brands in physical activity and health research. Recently, in February 2022, ActiGraph published their activity count algorithm and released a Python package for generating activity counts from raw acceleration data for five generations of ActiGraph devices. The nonproprietary derivation of the ActiGraph count improved the transparency and interpretation of accelerometer device-measured physical activity, but the Python release of the count algorithm does not integrate with packages developed by the physical activity research community using the R Statistical Programming Language.